Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid

@inproceedings{Maki2014PhosphodiesteraseII,
  title={Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid},
  author={Takakuni Maki and Yoko Okamoto and Roxana O. Carare and Yoshiki Hase and Yorito Hattori and Cheryl A. Hawkes and Satoshi Saito and Yumi Yamamoto and Yasukazu Terasaki and Hatsue Ishibashi-Ueda and A. Hisanori Taguchi and Ryosuke Takahashi and Taihei Miyakawa and Raj N Kalaria and Eng H. Lo and Ken Arai and Masafumi Ihara},
  booktitle={Annals of clinical and translational neurology},
  year={2014}
}
OBJECTIVE Brain amyloidosis is a key feature of Alzheimer's disease (AD). It also incorporates cerebrovascular amyloid β (Aβ) in the form of cerebral amyloid angiopathy (CAA) involving neurovascular dysfunction. We have recently shown by retrospective analysis that patients with mild cognitive impairment receiving a vasoactive drug cilostazol, a selective inhibitor of phosphodiesterase (PDE) III, exhibit significantly reduced cognitive decline. Here, we tested whether cilostazol protects… CONTINUE READING
Highly Cited
This paper has 61 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
18 Citations
54 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

62 Citations

0204020142015201620172018
Citations per Year
Semantic Scholar estimates that this publication has 62 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Similar Papers

Loading similar papers…